The present invention pertains to anti-MIF antibodies, in particular their use in combination with glucocorticoids, in the treatment of glycocorticoid receptive diseases.LA INVENCIÓN PROPORCIONA UNA TERAPIA DE COMBINACIÓN DE ANTICUERPOS ANTI-MIF Y GLUCOCORTICOIDES